Document:

EXHIBIT 10.3

                              EMPLOYMENT AGREEMENT

THIS AGREEMENT made this 31st day of May 2005.

BETWEEN:

      Oriens Life Sciences (Israel), Ltd., a body corporate with an address of

      21 Ahavat Zion St. Tel Aviv, Israel, 62153

      (the "Company")

AND:

      Shay Goldstein, an individual currently residing at

      21 Ahavat Zion St. Tel Aviv, Israel, 62153

      (the "Executive")

THIS AGREEMENT made this ___ day of _________, 2005.

BETWEEN:

      Oriens Life Sciences (Israel), Ltd., a body corporate with an address of
      ____________________

      (the "Company")

AND:

      Shay Goldstein, an individual currently residing at
      _______________________

      (the "Executive")

A. The Company has agreed to engage the Executive to serve in the role of the
Chief Executive Officer of the Company;

B. The Executive and the Company wish to formally record the terms and
conditions upon which the Executive will be employed by the Company and that
each of the Company and the Executive have agreed to the terms and conditions
set forth in this Agreement, as evidenced by their execution hereof.

<PAGE>

NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the premises and
the mutual covenants and agreements herein contained, the parties hereto
covenant and agree as follows:

                                    Article 1
                              CONTRACT FOR SERVICES

1.1 Engagement of Executive. Subject to earlier termination of the Agreement as
hereinafter provided, the Company hereby agrees to employ the Executive in
accordance with the terms and provisions hereof. The Executive shall serve as
the CEO of the Company and shall perform his duties hereunder at the Company's
facilities in Israel; however, the Executive acknowledges and agrees that the
performance of his duties hereunder may require significant domestic and
international travel.

1.2 Further Engagement of Executive. In addition, the Executive is employed as
the CEO of the Company's parent company, SafeTek International Inc. (the "Parent
Company"), without being entitled to any compensation other than the salary and
additional compensation to which he is entitled pursuant to this Agreement.

1.3 Term. Unless terminated earlier in accordance with the provisions hereof,
the term of employment under this Agreement shall commence on May1st, 2005 and
shall continue until terminated by either party as provided herein (the "Term").

1.4 Exclusive Service. The Executive agrees to faithfully, honestly and
diligently serve the Company and to devote the Executive's time, attention and
best efforts to further the business and interests of the Company during the
period of this Agreement to the exclusion of all other employment unless
specifically authorized by the Company.

1.5 Duties. The Executive's services hereunder shall be provided on the basis of
the following terms and conditions:

      (a)   reporting directly to the Board of Directors of the Company, the
            Executive shall serve as the CEO of the Company;

      (b)   the Executive shall be responsible for setting the overall corporate
            direction for the Company, including establishing and maintaining
            budgets for the Company and ensuring the Company has adequate
            capital for its operations, marketing and general corporate
            activities, all subject to any applicable law and to instructions
            provided by the Board of Directors of the Company from time to time;

      (c)   the Executive shall faithfully, honestly and diligently serve the
            Company and cooperate with the Company and utilize maximum
            professional skill and care to ensure that all services rendered
            hereunder are to the satisfaction of the Company, acting reasonably,
            and the Executive shall provide any other services not specifically
            mentioned herein, but which by reason of the Executive's capability

<PAGE>

            the Executive knows or ought to know to be necessary to ensure that
            the best interests of the Company are maintained;

      (d)   the Executive shall assume, obey, implement and execute such duties,
            directions, responsibilities, procedures, policies and lawful orders
            as may be determined or given from time to time by the Company; and

      (e)   the Executive shall report the results of his duties hereunder to
            the Company as it may request from time to time.

                                    Article 2
                                  COMPENSATION

2.1   Salary.

      (a)   For services rendered by the Executive during the Term, the
            Executive shall be paid throughout the Term a monthly salary,
            payable within 10 days after the end of each month (the "Salary").
            Notwithstanding the above, the Executive hereby agrees that the
            Salary to which the Executive shall be entitled until the closing of
            investments of an aggregate amount of at least US$ 40,000 in the
            Parent Company (the "Effective Date") shall only be paid to the
            Executive within three business days after the Effective Date.

      (b)   During the first three months in which the Executive receives a
            Salary, the gross monthly Salary shall be US$ 6,000; during the
            fourth through sixth months in which the Executive receives a
            Salary, the gross monthly Salary shall be US$ 7,500; and thereafter
            the Executive's gross monthly Salary shall be US$ 8,500.

      (c)   The Salary shall be paid in NIS translated pursuant to the official
            representative rate of exchange of the US$ as published by the Bank
            of Israel on the payment date. Any deductions required to be made by
            the Company and submitted to relevant tax or other authorities will
            be deducted at source.

      (d)   The Executive's Assignment is included among the positions of
            management or those requiring a special degree of personal trust,
            and the Company is not able to supervise the number of working hours
            of the Executive; therefore the provisions of the Israel Hours of
            Work and Rest Law - 1951, will not apply to the Executive and he
            will not be entitled to any additional remuneration whatsoever for
            his work with the exception of that specifically set out in this
            Agreement.

2.2 Bonus. In addition, if the aggregate investments made in the Company and/or
the Parent Company after the date hereof exceed an amount of US$ 4,000,000, then
the Executive shall be entitled to a bonus in the amount of US$ 8,500.

<PAGE>

2.3 Options. The Executive shall be entitled to participate in the employee
stock option plan to be adopted by the Parent Company (the "ESOP"), to an extent
determined at the sole discretion of the Parent Company's Board of Directors,
and only following and pending the adoption of the ESOP by the Parent Company.

2.4 Expenses. The Executive will be reimbursed by the Company for all reasonable
business expenses incurred by the Executive in connection with his duties within
previously approved budgets upon submission of a monthly statement of expenses.
This includes, but not only, full use of cellular phone, use of one dedicated
telephone/data line at home, daily newspaper, payments of expenses incurred when
traveling abroad, per diem payments for travel abroad according to the rules set
forth by the Israeli Tax Authorities and others. The Executive shall bear any
tax payments resulting from the aforesaid, to the extant applicable.

2.5 Company Vehicle. The Executive shall be entitled to the use of a [Licensing
Class 5] vehicle, as shall be determined by the Company, for which the Company
shall incur all reasonable expenses associated therewith, but excluding personal
traffic fines and the like. The use of such car shall be subject to the
Company's instructions, as may be amended from time to time. The Executive shall
bear any tax payments resulting from the aforesaid, to the extant applicable

2.6 Vacation; Recreation Pay. The Executive shall be entitled to cumulative paid
vacations of 20 days per year. In addition, Executive shall be entitled to sick
leave and Recreation Pay according to applicable law. Executive shall be
entitled to cash redemption of vested vacation upon termination of this
agreement, with or without cause, according to Israeli Labor Law and practice.

2.7 Deductions. The Executive acknowledges that all payments by the Company in
respect of the services provided by the Executive shall be net of all amounts
which the Company as employer is required to deduct or withhold from Salary or
other payments to an executive in accordance with statutory requirements
(including, without limitation, income tax, employee contributions and
unemployment insurance contributions).

                                    Article 3
                          Social Insurance and Benefits

3.1 Managers Insurance. The Company shall insure Executive under an accepted
"Manager's Insurance Scheme", which in each case shall provide insurance in the
event of illness or disability (hereinafter referred to as the "Managers
Insurance") as follows: (i) the Company shall pay an amount equal up to 7.5% of
Executive's Salary towards the Managers Insurance for Executive's benefit and
Disability Insurance and shall deduct 5% from Executive's Salary and pay such
amount towards the Managers Insurance for Executive's benefit (the various
components of the Managers Insurance shall be fixed at the discretion of
Executive); and (ii) the Company shall pay an amount equal to 8 1/3% of
Executive's Salary towards a fund for severance compensation which shall be

<PAGE>

payable to Executive upon severance, subject to provisions of Section 3.3
herein. The aforementioned allocations shall be in lieu of severance pay
according to the Israeli Severance Pay Law - 1963.

3.2 Keren Hishtalmut Fund. The Company and Executive shall open and maintain a
Keren Hishtalmut Fund. The Company shall contribute to such Fund an amount equal
to 7-1/2% of each monthly Salary payment, and Executive shall contribute to such
Fund an amount of up to 2-1/2% of each monthly Salary payment. Executive hereby
instructs the Company to transfer to such Fund the amount of Executive's and the
Company's contribution from each monthly Salary payment. Notwithstanding the
above, if the amounts to be contributed to the Keren Hishtalmut Fund will exceed
the amount exempt from tax pursuant to the applicable tax regulations, any
amount so exceeding shall not be transferred to such Fund but shall be added to
the Salary.

3.3 Effect of Termination. Upon termination of this Agreement by either party,
other than in circumstances constituting Cause (as defined below), the Company
shall assign and transfer to the Executive, after Executive has met all of
Executive's obligations hereunder in connection with such termination of
employment, the ownership in the aforesaid Manager's Insurance and Keren
Hishtalmut Fund. In the event that this Agreement is terminated in circumstances
constituting Cause, the Company, in its absolute discretion, may retain its
payments to such funds and release to the Executive only those sums contributed
by Executive to such funds.

3.4 Liability Insurance Indemnification. Within a reasonable period of time
following the signing of this agreement, the Company shall provide the Executive
with coverage under a standard directors' and officers' liability insurance
policy, at the Company's expense. In addition, the Executive shall be granted
indemnification by the Parent Company in connection with his position therein.

<PAGE>

                                    Article 4
                                 CONFIDENTIALITY

4.1 Maintenance of Confidential Information. The Executive acknowledges that in
the course of employment hereunder the Executive will, either directly or
indirectly, have access to and be entrusted with information (whether oral,
written or by inspection) relating to the Company or its Parent Company or their
respective affiliates, associates or customers (the "Confidential Information").
For the purposes of this Agreement, "Confidential Information" includes, without
limitation, any and all Developments (as defined herein), trade secrets,
inventions, innovations, techniques, processes, formulas, drawings, designs,
products, systems, creations, improvements, documentation, data, specifications,
technical reports, customer lists, supplier lists, distributor lists,
distribution channels and methods, retailer lists, reseller lists, employee
information, financial information, sales or marketing plans, competitive
analysis reports and any other thing or information whatsoever, whether
copyrightable or uncopyrightable or patentable or unpatentable. The Executive
acknowledges that the Confidential Information constitutes a proprietary right,
which the Company is entitled to protect. Accordingly the Executive covenants
and agrees that during the Term and thereafter until such time as all the
Confidential Information becomes publicly known and made generally available
through no action or inaction of the Executive, the Executive will keep in
strict confidence the lineConfidential Information and shall not, without prior
written consent of the Company, disclose, use or otherwise disseminate the
Confidential Information, directly or indirectly, to any third party.

4.2 Exceptions. The general prohibition contained in Section 4.1 against the
unauthorized disclosure, use or dissemination of the Confidential Information
shall not apply in respect of any Confidential Information that:

      (a)   is available to the public generally in the form disclosed;

      (b)   becomes part of the public domain through no fault of the Executive;

      (c)   is already in the lawful possession of the Executive at the time of
            receipt of the Confidential Information; or

      (d)   is compelled by applicable law to be disclosed, provided that the
            Executive gives the Company prompt written notice of such
            requirement prior to such disclosure and provides assistance in
            obtaining an order protecting the Confidential Information from
            public disclosure.

4.3 Developments. Any information, technology, technical data or any other thing
or documentation whatsoever which the Executive, either by himself or in
conjunction with any third party, has conceived, made, developed, acquired or
acquired knowledge of during the Executive's employment with the Company or
which the Executive, either by himself or in conjunction with any third party,

<PAGE>

shall conceive, make, develop, acquire or acquire knowledge of (collectively the
"Developments") during the Term or at any time thereafter during which the
Executive is employed by the Company that is related to conducting research and
clinical study shall automatically form part of the Confidential Information and
shall become and remain the sole and exclusive property of the Company.
Accordingly, the Executive does hereby irrevocably, exclusively and absolutely
assign, transfer and convey to the Company in perpetuity all worldwide right,
title and interest in and to any and all Developments and other rights of
whatsoever nature and kind in or arising from or pertaining to all such
Developments created or produced by the Executive during the course of
performing this Agreement, including, without limitation, the right to effect
any registration in the world to protect the foregoing rights. The Company shall
have the sole, absolute and unlimited right throughout the world, therefore, to
protect the Developments by patent, copyright, industrial design, trademark or
otherwise and to make, have made, use, reconstruct, repair, modify, reproduce,
publish, distribute and sell the Developments, in whole or in part, or combine
the Developments with any other matter, or not use the Developments at all, as
the Company sees fit.

4.4 Protection of Developments. The Executive does hereby agree that, both
before and after the termination of this Agreement, the Executive shall perform
such further acts and execute and deliver such further instruments, writings,
documents and assurances (including, without limitation, specific assignments
and other documentation which may be required anywhere in the world to register
evidence of ownership of the rights assigned pursuant hereto) as the Company
shall reasonably require in order to give full effect to the true intent and
purpose of the assignment made under Section 4.3 hereof. If the Company is for
any reason unable, after reasonable effort, to secure execution by the Executive
on documents needed to effect any registration or to apply for or prosecute any
right or protection relating to the Developments, the Executive hereby
designates and appoints the Company and its duly authorized officers and agents
as the Executive's agent and attorney to act for and in the Executive's behalf
and stead to execute and file any such document and do all other lawfully
permitted acts necessary or advisable in the opinion of the Company to effect
such registration or to apply for or prosecute such right or protection, with
the same legal force and effect as if executed by the Executive.

4.5 Fiduciary Obligation. The Executive declares that the Executive's
relationship to the Company is that of fiduciary, and the Executive agrees to
act towards the Company and otherwise behave as a fiduciary of the Company.

4.6 Remedies. The parties to this Agreement recognize that any violation or
threatened violation by the Executive of any of the provisions contained in this
Article 4. will result in immediate and irreparable damage to the Company and
that the Company could not adequately be compensated for such damage by monetary
award alone. Accordingly, the Executive agrees that in the event of any such
violation or threatened violation, the Company shall, in addition to any other
remedies available to the Company at law or in equity, be entitled as a matter
of right to apply to such relief by way of restraining order, temporary or
permanent injunction and to such other relief as any court of competent
jurisdiction may deem just and proper.

<PAGE>

4.7 Reasonable Restrictions. The Executive agrees that all restrictions in this
Article 4 are reasonable and valid, and all defenses to the strict enforcement
thereof by the Company are hereby waived by the Executive.

                                    Article 5
                                 Non-Competition

5.1 Non Competition. Executive agrees and undertakes that he will not, so long
as he is employed by the Company and for a period of 12 months following
termination of his employment for whatever reason, directly or indirectly, as
owner, partner, joint venture, stockholder, employee, broker, agent, principal,
corporate officer, director, licensor or in any other capacity whatever engage
in, become financially interested in, be employed by, or have any connection
with any business or venture that competes with the Company's business,
including any business which, when this Agreement terminates, the Company
contemplates in good faith to be materially engaged in within 12 months
thereafter, provided that the Company has taken demonstrable actions to promote
such engagement or that the Company's Board of Directors has adopted a
resolution authorizing such actions prior to the date of termination; provided,
however, that Executive may own securities of any corporation which is engaged
in such business and is publicly owned and traded but in an amount not to exceed
at any one time one percent (1%) of any class of stock or securities of such
company, so long as he has no active role in the publicly owned and traded
company as director, employee, consultant or otherwise.

5.2 No Solicitation. Executive agrees and undertakes that during the period of
his employment and for a period of 12 months following termination, he will not,
directly or indirectly, including personally or in any business in which he is
an officer, director or shareholder, for any purpose or in any place, employ any
person (as an employee or consultant) employed by the Company at such time or
during the preceding twelve months, unless such person has been terminated by
the Company, provided however, that such person who is terminated by the Company
may be employed by Executive as described above only after the expiration of
twelve months after the effective date of such termination.

                                    Article 6
                                   termination

6.1 Termination For Cause or Disability. This Agreement may be terminated at any
time by the Company without notice, for Cause or in the event of the Disability
of Executive.

      For the purposes of this Agreement, "Cause" also means that the Executive
      shall have:

<PAGE>

      (a)   committed an intentional act of fraud, embezzlement or theft in
            connection with the Executive's duties or in the course of the
            Executive's employment with the Company;

      (b)   intentionally and wrongfully damaged property of the Company, or any
            of its respective affiliates, associates or customers;

      (c)   intentionally or wrongfully disclosed any of the Confidential
            Information;

      (d)   made material personal benefit at the expense of the Company without
            the prior written consent of the management of the Company;

      (e)   accepted shares or options or any other gifts or benefits from a
            vendor without the prior written consent of the management of the
            Company;

      (f)   fundamentally breached any of the Executive's material covenants
            contained in this Agreement; or

      (g)   willfully and persistently, without reasonable justification, failed
            or refused to follow the lawful and proper directives of the Company
            specifying in reasonable detail the alleged failure or refusal and
            after a reasonable opportunity for the Executive to cure the alleged
            failure or refusal.

      For the purposes of this Agreement, an act or omission on the part of the
      Executive shall not be deemed "intentional," if it was due to an error in
      judgment or negligence, but shall be deemed "intentional" if done by the
      Executive not in good faith and without reasonable belief that the act or
      omission was in the best interests of the Company, or its respective
      affiliates, associates or customers.

      For the purposes of this Agreement, "Disability" shall mean any physical
      or mental illness or injury as a result of which Executive remains absent
      from work for a period of six (6) successive months, or an aggregate of
      six (6) months in any twelve (12) month period. Disability shall occur
      upon the end of such six-month period.

6.2 Severance for Termination With Cause. If the Company terminates the
Executive's employment for Cause, then the Company will not be obligated to pay
the Executive any severance payments or provide any notice whatsoever to the
Executive.

6.3 Termination Without Cause. Either the Executive or the Company may terminate
the Executive's employment without Cause, for any reason whatsoever, with 30
days notice within the first year of the Executive's engagement and with 90 days
prior written notice thereafter.

6.4 The Notice Period.

<PAGE>

      (a)   During the period following the notice of termination (the "Notice
            Period"), Executive shall cooperate with the Company and use his
            best efforts to assist the integration into the Company's
            organization of the person or persons who will assume Executive's
            responsibilities.

      (b)   This Agreement shall remain in full force and effect until the end
            of the Notice Period and there shall be no change in Executive's
            compensation terms or any of his obligations hereunder during such
            Notice period.

      (c)   Notwithstanding sub-section (b) above, during the Notice Period the
            Company may, at its discretion, relieve Executive of his position,
            upon which Executive shall leave the Company. Such actions shall not
            derogate in any way or manner whatsoever from Executive's rights to
            receive the Salary until the end of the Notice period.

6.5 Limitation of Damages. It is agreed that in the event of termination of
employment, neither the Company, nor the Executive shall be entitled to any
notice, or payment in excess of that specified in this Article 6.

6.6 Return of Materials. Within three (3) days of any termination of employment
hereunder, or upon any request by the Company at any time, the Executive will
return or cause to be returned any and all Confidential Information and other
assets of the Company (including all originals and copies thereof), which
"assets" include, without limitation, hardware, software, keys, security cards
and backup tapes that were provided to the Executive either for the purpose of
performing the employment services hereunder or for any other reason. The
Executive acknowledges that the Confidential Information and the assets are
proprietary to the Company, and the Executive agrees to return them to the
Company in the same condition as the Executive received such Confidential
Information and assets.

6.7 Effect of Termination. Articles 3.3, 3.4, 4, 5 and 6.6 hereto shall remain
in full force and effect after termination of this Agreement, for any reason
whatsoever.

                                    Article 7
                             Mutual Representations

7.1 Executive represents and warrants to the Company that the execution and
delivery of this Agreement and the fulfillment of the terms hereof (i) will not
constitute a default under or conflict with any agreement or other instrument to
which he is a party or by which he is bound, and (ii) do not require the consent
of any person or entity.

7.2 The Company represents and warrants to Executive that this Agreement has
been duly authorized, executed and delivered by the Company and that the
fulfillment of the terms hereof (i) will not constitute a default under or
conflict with any agreement of other instrument to which it is a party or by
which it is bound, and (ii) do not require the consent of any person of entity.

<PAGE>

7.3 Each party hereto warrants and represents to the other that this Agreement
constitutes the valid and binding obligation of such party enforceable against
such party in accordance with its terms subject to applicable bankruptcy,
insolvency, moratorium and similar laws affecting creditors' rights generally,
and subject, as to enforceability, to general principles of equity (regardless
if enforcement is sought in proceeding in equity or at law).

                                    Article 8
                                     Notices

8.1 Notices. All notices required or allowed to be given under this Agreement
shall be made either personally by delivery to or by facsimile transmission to
the address as hereinafter set forth or to such other address as may be
designated from time to time by such party in writing:

      (a)   in the case of the Company, to:

                     Oriens Life Sciences (Israel) Ltd.
                     _____________
                     Attn: _______
                     Fax: ________

            with a copy to

                     Ori Rosen, Adv.
                     Ori Rosen & Co. Law Offices, 1 Azrieli Center
                      (Round Building)
                     Tel Aviv 67021, Israel
                     Fax: 972-3-607-4701
                     Email: ori@rosenlaw.co.il

      (b)   and in the case of the Executive, to the Executive's last residence
            address known to the Company.

8.2 Change of Address. Any party may, from time to time, change its address for
service hereunder by written notice to the other party in the manner aforesaid.

                                    Article 9
                                     GENERAL

9.1 Entire Agreement. As of from the date hereof, any and all previous
agreements, written or oral between the parties hereto or on their behalf
relating to the employment of the Executive by the Company are null and void.
The parties hereto agree that they have expressed herein their entire
understanding and agreement concerning the subject matter of this Agreement and
it is expressly agreed that no implied covenant, condition, term or reservation
or prior representation or warranty shall be read into this Agreement relating

<PAGE>

to or concerning the subject matter hereof or any matter or operation provided
for herein.

9.2 Personal Agreement. The provisions of this Agreement are in lieu of the
provisions of any collective bargaining agreement, and therefore, no collective
bargaining agreement shall apply with respect to the relationship between the
parties hereto (subject to the applicable provisions of law).

9.3 Further Assurances. Each party hereto will promptly and duly execute and
deliver to the other party such further documents and assurances and take such
further action as such other party may from time to time reasonably request in
order to more effectively carry out the intent and purpose of this Agreement and
to establish and protect the rights and remedies created or intended to be
created hereby.

9.4 Waiver. No provision hereof shall be deemed waived and no breach excused,
unless such waiver or consent excusing the breach is made in writing and signed
by the party to be charged with such waiver or consent. A waiver by a party of
any provision of this Agreement shall not be construed as a waiver of a further
breach of the same provision.

9.5 Amendments in Writing. No amendment, modification or rescission of this
Agreement shall be effective unless set forth in writing and signed by the
parties hereto.

9.6 Assignment. Except as herein expressly provided, the respective rights and
obligations of the Executive and the Company under this Agreement shall not be
assignable by either party without the written consent of the other party and
shall, subject to the foregoing, enure to the benefit of and be binding upon the
Executive and the Company and their permitted successors or assigns. Nothing
herein expressed or implied is intended to confer on any person other than the
parties hereto any rights, remedies, obligations or liabilities under or by
reason of this Agreement.

9.7 Severability. In the event that any provision contained in this Agreement
shall be declared invalid, illegal or unenforceable by a court or other lawful
authority of competent jurisdiction, such provision shall be deemed not to
affect or impair the validity or enforceability of any other provision of this
Agreement, which shall continue to have full force and effect.

9.8 Headings. The headings in this Agreement are inserted for convenience of
reference only and shall not affect the construction or interpretation of this
Agreement.

9.9 Number and Gender. Wherever the singular or masculine or neuter is used in
this Agreement, the same shall be construed as meaning the plural or feminine or
a body politic or corporate and vice versa where the context so requires.

9.10 Time. Time shall be of the essence of this Agreement.

9.11 Governing Law. This Agreement shall be construed and interpreted in
accordance with the laws of the state of Israel applicable therein, and each of

<PAGE>

the parties hereto expressly attorns to the jurisdiction of the courts of the
state of Israel. The sole and exclusive place of jurisdiction in any matter
arising out of or in connection with this Agreement shall be the applicable
Tel-Aviv court.

9.12 Enurement. This Agreement is intended to bind and enure to the benefit of
the Company, its successors and assigns, and the Executive and the personal
legal representatives of the Executive.

                [Remainder of this page left intentionally blank]

<PAGE>

IN WITNESS WHEREOF the parties hereto have executed this Agreement effective as
of the date and year first above written.

ORIENS LIFE SCIENCES (ISRAEL) LTD.          EXECUTIVE

Per:  /s/ Shay Goldstein                  /s/ Shay Goldstein
      ---------------------------         -----------------------------
Name: Shay Goldst ein                     Shay Goldstein

Title:  Chairman, Chief Executive Officer,
                              Secretary, and DirectorEXHIBIT 10.4

                              Consulting Agreement

This consulting agreement (the "Agreement") is entered into as of the _____ 7th
day of June, 2005, by and among Oriens Life Sciences (Israel), Ltd., a company
incorporated under the laws of the State of Israel, with its principal office at
21 Ahavat Zion, Tel Aviv, Israel 62153 (the "Company"), and Ms. Tamar Tzaban -
Nahumov of 6 Dov Hoz St., Kiryat Ono, Israel (the "Consultant").

Whereas, Consultant is engaged in the provision of advisory services as provided
herein; and

Whereas, the Company desires to retain certain services from Consultant, and
Consultant desires to provide such services to Company;

Now, therefore, in consideration of their respective undertakings herein
contained, and other considerations, the sufficiency of which is hereby
acknowledged, the parties hereto hereby agree as follows:

1.    Term; Termination. This Agreement shall commence on the date hereof and
      shall continue until terminated by either party, for any reason
      whatsoever, upon prior written notice of 30 days (the "Consulting Term").
      However, Company may terminate this Agreement immediately without an
      advance notice, and without derogating from any other remedy to which
      Company may be entitled, in the event of: (i) the willful malfeasance or
      gross negligence in the performance of Consultant's obligations under this
      Agreement; (ii) the commission by Consultant of a felony or other criminal
      conduct involving fraud, dishonesty, theft or misappropriation, or (iii)
      the material breach of any applicable duty of loyalty to Company or
      unauthorized use or disclosure, misappropriation, destruction or diversion
      of any material tangible or intangible asset or corporate opportunity of
      Company, or other material tortuous or unlawful conduct which is injurious
      to Company or an affiliate thereof.

2.    The Services.

      2.1.  Beginning on May 15th, 2005 (the "Commencement Date"), Consultant is
            engaged by Company to provide Company with advisory services,
            concerning such financial matters as shall be reasonably requested
            by the Company from time to time (the "Services"). The scope of the
            Services shall be similar to the duties of a Chief Financial Officer
            (CFO) of the Company, as determined from time to time by the Board
            of Directors of Company.

<PAGE>

      2.2.  The Consultant shall devote no less than 20 weekly working hours, as
            well as all required know-how, energy, expertise, talent, experience
            and best efforts in order to provide the Services hereunder.
            Consultant confirms that she is available to provide such required
            services. Company confirms that subject to the provisions of this
            Agreement (including, without limitation, the provisions of Exhibit
            A hereto concerning proprietary information, confidentiality and
            non-competition), Consultant is and may be employed for other
            business or professional activities.

      2.3.  Consultant shall utilize the highest professional skill, diligence,
            ethics and care to ensure that all Services are performed to the
            full satisfaction of Company and to provide the expertise required
            in connection with such Services.

3.    Compensation and Reimbursement

      3.1.  Company shall pay Consultant, as full compensation for the provision
            of all Services hereunder, a monthly amount (the "Fee") equal to (i)
            for every month in which Consultant devotes to the performance of
            the Services at least 20 weekly working hours, but no more than 25
            weekly working hours - $3,500; or (ii) for every month in which
            Consultant devotes to the performance of the Services, at the
            request of the Company, at least 25 weekly working hours - $5,000.
            The Fee will be payable against a valid invoice furnished by
            Consultant to Company. The Company shall add V.A.T. to all Fee
            payments, as required under applicable law, against receipt of an
            invoice. The Fee shall be paid within 10 days of the end of each
            month.

      3.2.  The Company shall reimburse Consultant for out of pocket expenses
            incurred in connection with the performance of her duties under this
            Agreement, only if the same has been approved in advance and in
            writing by the Company. As a condition to reimbursement, Consultant
            shall provide Company with all invoices, receipts and other evidence
            of expenditure as may be reasonably required by Company from time to
            time.

      3.3.  The Fee constitutes the full and final consideration for the
            Services, and Consultant shall not be entitled to any additional
            consideration, of any form, for the Services, except as detailed in
            Section 3.4 hereunder. By signing at the end of this Agreement, the
            Consultant acknowledges and agrees that as a service provider to
            Company she is not entitled to receive from Company any social
            benefits (including without limitation, paid vacation days, paid
            sick leave, severance payments, pension funds, etc.) to which she
            may be entitled under any applicable law.

<PAGE>

      3.4.  Consultant shall be entitled to participate in the employee stock
            option plan to be adopted by the Company's parent company, SafeTek
            International Inc. ("SafeTek"), to an extent that shall be agreed
            between the parties to this Agreement at a later date, and subject
            to future approval by SafeTek and to all relevant terms to be set
            forth by SafeTek in said employee stock option plan.

4.    Confidentiality; Non-Competition

      By executing this Agreement, Consultant confirms and agrees to the
      provisions of Company's Proprietary Information, Confidentiality and
      Non-Competition Agreement attached in Exhibit A hereto (an "NDA").

5.    Independent Contractor

      5.1.  Consultant agrees and acknowledges that she is performing the
            Services hereunder as an independent contractor and that no
            employer-employee relationship exists or will exist between
            Consultant and Company.

      5.2.  Consultant (by signing at the end of this Agreement) hereby fully
            and irrevocably represent, warrant and undertake as follows:

            5.2.1. Consultant was offered by Company the option to be employed
                  by Company in consideration of a monthly salary, with the
                  related social benefits, but Consultant declined and demanded
                  from Company that no employer-employee relations be
                  established between herself and Company, at her own initiative
                  and free will and based on her considerations.

            5.2.2. The Consulting Fee is the sole and exclusive consideration,
                  which Company shall be required to pay for all services
                  rendered to it.

            5.2.3. Consultant is stopped from making any claim regarding the
                  existence of employer-employee relations between Consultant
                  and the Company.

            5.2.4. If, despite the parties' express representations and
                  agreements hereunder, it shall, at any time, be determined by
                  a court of competent jurisdiction or by any other governmental
                  authority, that employer-employee relations exist between the
                  Company and Consultant, and as a result of such decision
                  Consultant shall become entitled to any rights and/or payments
                  resulting from the existence of such relations, and/or the
                  Company shall be required to bear any additional expenses or
                  costs (specifically including any taxes or obligatory payments

<PAGE>

                  to the tax authorities, the National Insurance authorities,
                  etc.), the parties agree and undertake that the "salary" to
                  which Consultant is entitled for her services as employee of
                  Company hereunder shall be equal to 60% (sixty percent) of the
                  Consulting Fee, and Consultant undertakes in such event to
                  immediately repay and return to Company any amounts received
                  hereunder in excess of said 60% (sixty percent) throughout the
                  entire term of the Agreement. Consultant further undertakes to
                  indemnify Company for any loss, payment, expense or damage
                  caused to the Company as a result of such decision. The
                  Company shall be entitled to set off any payment or grant of
                  securities to which Consultant may become entitled under such
                  decision from any payment or grant of securities due to
                  Consultant under this Agreement (including the forfeiture,
                  repurchase for par value, conversion into deferred stock and
                  the like actions).

6.    Representations by Consultant. Consultant represents and warrants to
      Company that the execution and delivery of this Agreement and the
      fulfillment of the terms hereof (i) will not constitute a default under or
      conflict with any agreement or other instrument to which she is a party or
      by which she is bound; (ii) will not result in a breach of any
      confidentiality undertaking to any third party; and (iii) do not require
      the consent of any person or entity.

7.    Miscellaneous. This Agreement constitutes the entire understanding between
      the parties with respect to the matters referred to herein. This Agreement
      shall be governed by the laws of the State of Israel, excluding its
      conflict of law rules, and the courts of Tel-Aviv-Jaffa shall have
      exclusive jurisdiction over the parties. This Agreement may not be
      assigned by Consultant. This Agreement may not be amended or modified,
      except by the written consent of both parties hereto. No failure or delay
      on the part of any party hereto in exercising any right, power or remedy
      hereunder shall operate as a waiver thereof. Headings to Sections herein
      are for the convenience of the parties only, and are not intended to be or
      to affect the meaning or interpretation of this Agreement. In the event
      that any covenant, condition or other provision contained in this
      Agreement is held to be invalid, void or illegal by any court of competent
      jurisdiction, the same shall be deemed severable from the remainder
      thereof, and shall in no way affect, impair or invalidate any other
      covenant, condition or other provision therein contained. All notices
      required to be delivered under this Agreement shall be effective only if
      in writing and shall be deemed given when received by the party to whom
      notice is required to be given and shall be delivered personally, by
      registered mail, by fax or by means of electronic communication.

<PAGE>

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written.

/s/ Jean Pierre Elisha Martinez             /s/ Tamar Tzaban - Nahumov
------------------------------------        --------------------------
Oriens Life Sciences (Israel), Ltd.         Tamar Tzaban - Nahumov
(Company)                                   (Consultant)

/s/ Shay Goldstein
------------------------------------
Oriens Life Sciences (Israel), Ltd.
(Company)

<PAGE>

                                    Exhibit A

This Proprietary Information, Confidentiality and Non-Competition Agreement is
attached as Exhibit A to that certain Services Agreement by and between Oriens
Life Sciences (Israel), Ltd., (the "Company") and Tamar Tzaban - Nahumov
("Consultant") (the "Agreement").

All the capitalized terms herein shall have the meanings ascribed to them in the
Agreement. For purposes hereof, the term "Company" shall mean and include the
Company, its parent company SafeTek International Inc., and any of their
subsidiaries and affiliates.

Consultant's obligations and representations and Company's rights under this
Exhibit shall apply as of the time she first became engaged with Company,
regardless of the date of execution of the Agreement.

Confidentiality; Proprietary Information

1.    "Proprietary Information" means confidential and proprietary information
      concerning the business and financial activities of Company, including
      patents, patent applications, trademarks, copyrights and other
      intellectual property, and information relating to the same, technologies
      and products (actual or planned), know how, inventions, research and
      development activities, inventions, trade secrets and industrial secrets,
      and also confidential commercial information such as investments,
      investors, employees, customers, suppliers, marketing plans, etc., all the
      above - whether documentary, written, oral or computer generated.
      Proprietary Information shall also include information of the same nature
      which Company may obtain or receive from third parties.

2.    Proprietary Information shall be deemed to include any and all proprietary
      information disclosed by or on behalf of Company and irrespective of form
      but excluding information that (i) was known to Consultant prior to
      Consultant's association with Company and can be so proven; (ii) is or
      shall become part of the public knowledge except as a result of the breach
      of the Agreement or this Exhibit by Consultant; (iii) reflects general
      skills and experience gained during Consultant's engagement by Company; or
      (iv) reflects information and data generally known in the industries or
      trades in which Company operates.

3.    Consultant recognizes that Company received and will receive confidential
      or proprietary information from third parties, subject to a duty on
      Company's part to maintain the confidentiality of such information and to
      use it only for certain limited purposes. In connection with such duties,
      such information shall be deemed Proprietary Information hereunder,
      mutatis mutandis.

<PAGE>

4.    Consultant agrees that all Proprietary Information, and patents,
      trademarks, copyrights and other intellectual property and ownership
      rights in connection therewith shall be the sole property of Company its
      subsidiaries and their assigns. At all times, both during the term of
      Consultant's engagement with Company (the "Term") and after the
      termination of the engagement between the parties, Consultant will keep in
      confidence and trust all Proprietary Information, and Consultant will not
      use or disclose any Proprietary Information or anything relating to it
      without the written consent of Company or its subsidiaries, except as may
      be necessary in the ordinary course of performing Consultant's duties
      under the Agreement.

5.    Upon termination of Consultant's engagement with Company, Consultant will
      promptly deliver to Company all documents and materials of any nature
      pertaining to Consultant's engagement with Company, and will not take with
      his any documents or materials or copies thereof containing any
      Proprietary Information.

6.    Consultant's undertakings set forth in Section 1 through Section 6 of this
      Exhibit shall remain in full force and effect after termination of the
      Agreement or any renewal thereof.

Disclosure and Assignment of Inventions

7.    "Inventions" means any and all inventions, improvements, designs,
      concepts, techniques, methods, systems, processes, know how, computer
      software programs, databases, mask works and trade secrets, whether or not
      patentable, copyrightable or protectible as trade secrets; "Company
      Inventions" means any Inventions that are made or conceived or first
      reduced to practice or created by Consultant, whether alone or jointly
      with others, during the period of Consultant's engagement with Company,
      and which are: (i) developed using equipment, supplies, facilities or
      Proprietary Information of Company, (ii) result from work performed by
      Consultant for Company, or (iii) related to the field of business of
      Company, or to current or anticipated research and development.

8.    Consultant undertakes and covenants he will promptly disclose in
      confidence to Company all Inventions deemed as Company Inventions.

9.    Consultant hereby irrevocably transfers and assigns to Company all
      worldwide patents, patent applications, copyrights, mask works, trade
      secrets and other intellectual property rights in any Company Invention,
      and any and all moral rights that he may have in or with respect to any
      Company Invention.

<PAGE>

10.   Consultant agrees to assist Company, at Company's expense, in every proper
      way to obtain for Company and enforce patents, copyrights, mask work
      rights, and other legal protections for Company Inventions in any and all
      countries. Consultant will execute any documents that Company may
      reasonably request for use in obtaining or enforcing such patents,
      copyrights, mask work rights, trade secrets and other legal protections.
      Such obligation shall continue beyond the termination of Consultant's
      engagement with Company. Consultant hereby irrevocably designates and
      appoints Company and its authorized officers and agents as Consultant's
      agent and attorney in fact, coupled with an interest to act for and on
      Consultant's behalf and in Consultant's stead to execute and file any
      document needed to apply for or prosecute any patent, copyright,
      trademark, trade secret, any applications regarding same or any other
      right or protection relating to any Proprietary Information (including
      Company Inventions), and to do all other lawfully permitted acts to
      further the prosecution and issuance of patents, copyrights, trademarks,
      trade secrets or any other right or protection relating to any Proprietary
      Information (including Company Inventions), with the same legal force and
      effect as if executed by Consultant himself.

Non-Competition

11.   Consultant agrees and undertakes that he will not, so long as the
      Agreement is in effect and for a period of twelve (12) months following
      termination of the Agreement, for any reason whatsoever, directly or
      indirectly, in any capacity whatsoever, engage in, become financially
      interested in, be employed by, or have any connection with any business or
      venture that is, or will be during the Consulting Term, engaged in any
      activities competing with the activities of Company at such time.

12.   Consultant agrees and undertakes that during the Term and for a period of
      twelve (12) months following termination of his engagement for whatever
      reason, Consultant will not, directly or indirectly, including personally
      or in any business in which Consultant may be an officer, director or
      shareholder, solicit for employment any person who is employed by Company,
      or any person retained by Company as a consultant, advisor or the like who
      is subject to an undertaking towards Company to refrain from engagement in
      activities competing with the activities of Company, or was retained as an
      employee or a consultant, advisor or the like during the six months
      preceding termination of the Term.

<PAGE>

Reasonableness of Protective Covenants

13.   Insofar as the protective covenants set forth in this Exhibit are
      concerned, Consultant specifically acknowledges, stipulates and agrees as
      follows: (i) the protective covenants are reasonable and necessary to
      protect the goodwill, property and Proprietary Information of Company, and
      the operations and business of Company; and (ii) the time duration of the
      protective covenants is reasonable and necessary to protect the goodwill
      and the operations and business of Company, and does not impose a greater
      restrain than is necessary to protect the goodwill or other business
      interests of Company. Nevertheless, if any of the restrictions set forth
      in this Exhibit is found by a court having jurisdiction to be unreasonable
      or overly-broad as to geographic area, scope or time or to be otherwise
      unenforceable, the parties hereto intend for the restrictions set forth in
      this Exhibit to be reformed, modified and redefined by such court so as to
      be reasonable and enforceable and, as so modified by such court, to be
      fully enforced.

Remedies for Breach

14.   Consultant acknowledges that the legal remedies for breach of the
      provisions of this Exhibit may be found inadequate and therefore agrees
      that, in addition to all of the remedies available to Company in the event
      of a breach or a threatened breach of any of such provisions, Company may
      also, in addition to any other remedies which may be available under
      applicable law, obtain temporary, preliminary and permanent injunctions
      against any and all such actions.

Intent of Parties

15.   Consultant recognizes and agrees: (i) that this Exhibit is necessary and
      essential to protect the business of Company and to realize and derive all
      the benefits, rights and expectations of conducting Company's business;
      (ii) that the area and duration of the protective covenants contained
      herein are in all things reasonable; and (iii) that good and valuable
      consideration exists under the Agreement, for Consultant's agreement to be
      bound by the provisions of this Exhibit.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]